Prioritising Patient Medication Review: Hospitals Reaching Out

Recruiting N/A Interventional Study
Medication Review Polypharmacy General Practitioners Interdisciplinary Communication Clinical Pharmacy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
800 (estimated)
Sponsor
University of Southern Denmark · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To examine the effect of a cross-sectoral medication review intervention to admitted multi-morbid, polypharmacy patients aged 65+ at SHS in two settings; an acute admission unit (typical admission time \< 48 hours) and a medical outpatient setting (patients routinely visits for follow-up, diagnosis or treatment, but do require a bed or overnight care).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * all hospitalized patients who are prescribed at least seven medications specified in the Electronic Patient Journal (EPJ) at admission Exclusion Criteria: * terminal patients or patients with a short life expectancy, patients residing in another region, patients who are disc…
Contacts

Joo Hanne Poulsen Revell

+45 79974906

Joo.Hanne.Poulsen.Revell@rsyd.dk

CONTACT

Lene Juel Kjeldsen

+45 79974932

Lene.Juel.Kjeldsen@rsyd.dk

CONTACT